MCPHS in collaboration with Alexion, AstraZeneca Rare Disease is offering fellowship experience within Global Value, Access, and Pricing (GVAP) with an enriched Health Economics & Outcomes research (HEOR) experience.
Astrazeneca’s Rare Disease GVAP team is seeking a fellow to be part of a dynamic and growing team working in the metabolic portfolio. This is a strategic role leveraging your understanding and application of global healthcare, HTA system knowledge, competitive insights, and clinical background to shape market access, pricing and reimbursement success for critical product launches and indications.
This fellowship provides a unique opportunity to develop an expertise in the cross-section of GVAP & HEOR. Global market access and health economics are complimentary functions with HTA/payers as the core stakeholder and this fellowship is designed to combine the strategic components of HEOR and apply them to real-world global market access problems. As a fellow you will learn to lead the development and execution of value, access, and price strategies for launch assets to support patient access to our medicines. As key parts of the development team, we help shape the clinical development program, develop value propositions that help inform evidence generation activities, and establish pricing recommendations for products in our portfolio.
Value, Access, and Pricing Focused Objectives:
Support development of differentiated target product profile that fulfills cross stakeholder needs aligned to robust value proposition
Develop global pricing and reimbursement (P&R) strategies and framework in close collaboration with launch and program teams
Creation and roll out of value, and access communication tools and materials to support local P&R submissions and negotiations
Cultivate understanding of global health care, HTA systems, and latest developing trends especially within rare disease
Health Economics and Outcomes Research Focused Objectives:
Comprehensive understanding of what evidence payers value across market/payer archetypes
Fundamentals of economic modeling bridging to appreciation of level of evidence needed from payer perspective
Influencing trial design, outcomes, and endpoint strategy to support payer needs
Exposure to different methodologies to quantify and fill evidence gaps including burden of disease & unmet need
View the Alexion Fellowship Brochure for more information, or visit http://www.mcphs.edu/pharmdfellow for general program information
To be considered for an interview at Midyear, please register for both ASHP Midyear and PPS and then complete a fellowship application on the MCPHS SMApply application portal. Visit mcphs.smapply.io
The portal will open on October 2, 2023 at 8 am EST.
Please DO NOT request an interview within PPS. Our recruitment teams will contact qualified candidates via PPS to schedule interviews.
ASHP attendance is not required but highly recommended for in-person interviews.
Before ASHP Midyear Clinical Meeting
Applicants must upload the following application materials to the online portal by November 17, 2023:
Letter of intent
Unofficial college transcript
Contact information of three references for their recommendations.
Incomplete applications WILL NOT be reviewed. ASHP Clinical Midyear Meeting interviews CANNOT be scheduled until these materials have been submitted. Please keep in mind that this is a competitive process and applicants are encouraged to complete their applications as soon as possible.
Three recommendations must be submitted by the three provided contacts no later than November 27, 2023.
The MCPHS Biopharmaceutical Industry fellows will be selected on a nationally competitive basis, with interviews at the American Society of Health Systems Pharmacists (ASHP) Midyear meeting.
Applicants must have a Doctor of Pharmacy degree from an ACPE accredited college of pharmacy at the commencement of the program.
Candidates must have strong written and verbal communication skills and a strong interest in pursuing a career within the biopharmaceutical industry.
All candidates must have authorization to work in the United States throughout the duration of the one or two-year fellowship. No visa sponsorship will be provided.
Visit our website for more information: http://www.mcphs.edu/pharmdfellow
Employer will assist with relocation costs.
Additional Salary Information: Fellows will receive a competitive stipend and benefit package, including comprehensive health insurance.
Alexion, AstraZeneca’s Rare Disease group, was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. For more than 30 years, Alexion’s mission has been to transform the lives of people affected by rare diseases through the development and delivery of innovative medicines as well as supportive technologies and healthcare services. Dedicated to continuing its mission as part of AstraZeneca, Alexion leads with the knowledge that patients and caregivers are people first, and by seeking to understand their experiences, Alexion is better able to serve their unique needs.
Alexion’s pioneering legacy in rare diseases is rooted in being the first to translate the complex biology of the complement system into novel medicines. Alexion continues to push the boundaries of science to accelerate the discovery and development of new life-changing medicines for even more people affected by rare diseases. Headquartered in Boston, Massachusetts, Alexion has offices around the globe and continues to expand its reach to benefit the lives of more rare disease patients around the world.
MCPHS provides an academic environment to guide and support fellows toward a successful career ...in the biopharmaceutical industry. As a private institution with a history of specializing in health sciences, MCPHS offers programs that embody scholarship, professional service, and community outreach.
Through MCPHS, the fellow will have the opportunity to gain teaching and research experience in an academic setting. MCPHS faculty and company program leaders mentor fellows according to their scholarly and professional interests throughout the two-year program.
As an adjunct instructor at MCPHS, the fellow may have the opportunity to: develop, coordinate, and teach courses; co-precept pharmacy students on advanced experiential rotations; create and publish scholarly research and/or review articles; present research at scientific and clinical meetings; participate in professional development seminars with other fellows and residents from MCPHS-affiliated programs.